367 related articles for article (PubMed ID: 22895781)
1. Pyruvate uptake is increased in highly invasive ovarian cancer cells under anoikis conditions for anaplerosis, mitochondrial function, and migration.
Caneba CA; Bellance N; Yang L; Pabst L; Nagrath D
Am J Physiol Endocrinol Metab; 2012 Oct; 303(8):E1036-52. PubMed ID: 22895781
[TBL] [Abstract][Full Text] [Related]
2. Induction of anoikis and suppression of human ovarian tumor growth in vivo by down-regulation of Bcl-X(L).
Frankel A; Rosen K; Filmus J; Kerbel RS
Cancer Res; 2001 Jun; 61(12):4837-41. PubMed ID: 11406560
[TBL] [Abstract][Full Text] [Related]
3. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
4. [Anoikis-suppression and invasion induced by tyrosine kinase receptor B in OVCAR3 ovarian cancer cells].
Yu XH; Yang YX; Cai B; Yan Q; He YY; Wan XP
Zhonghua Fu Chan Ke Za Zhi; 2008 Sep; 43(9):695-9. PubMed ID: 19087522
[TBL] [Abstract][Full Text] [Related]
5. Comparison of metabolic flux distributions for MDCK cell growth in glutamine- and pyruvate-containing media.
Sidorenko Y; Wahl A; Dauner M; Genzel Y; Reichl U
Biotechnol Prog; 2008; 24(2):311-20. PubMed ID: 18215054
[TBL] [Abstract][Full Text] [Related]
6. Mathematical simulation of membrane processes and metabolic fluxes of the pancreatic beta-cell.
Diederichs F
Bull Math Biol; 2006 Oct; 68(7):1779-818. PubMed ID: 16832733
[TBL] [Abstract][Full Text] [Related]
7. Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts.
Fabian C; Koetz L; Favaro E; Indraccolo S; Mueller-Klieser W; Sattler UG
FEBS J; 2012 Mar; 279(5):882-91. PubMed ID: 22240028
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin increases oxidative metabolism in HL-1 cardiomyocytes as shown by 13C metabolic flux analysis.
Strigun A; Wahrheit J; Niklas J; Heinzle E; Noor F
Toxicol Sci; 2012 Feb; 125(2):595-606. PubMed ID: 22048646
[TBL] [Abstract][Full Text] [Related]
9. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
Pathania D; Millard M; Neamati N
Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
[TBL] [Abstract][Full Text] [Related]
10. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
11. The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes.
Li N; Zhan X; Zhan X
Gynecol Oncol; 2018 Aug; 150(2):343-354. PubMed ID: 29921511
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.
Moro L; Arbini AA; Yao JL; di Sant'Agnese PA; Marra E; Greco M
Cell Death Differ; 2009 Apr; 16(4):571-83. PubMed ID: 19079138
[TBL] [Abstract][Full Text] [Related]
13. Mesothelial vitronectin stimulates migration of ovarian cancer cells.
Heyman L; Leroy-Dudal J; Fernandes J; Seyer D; Dutoit S; Carreiras F
Cell Biol Int; 2010 Apr; 34(5):493-502. PubMed ID: 20121701
[TBL] [Abstract][Full Text] [Related]
14. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity.
Sood AK; Fletcher MS; Coffin JE; Yang M; Seftor EA; Gruman LM; Gershenson DM; Hendrix MJ
Am J Obstet Gynecol; 2004 Apr; 190(4):899-909. PubMed ID: 15118611
[TBL] [Abstract][Full Text] [Related]
15. Metabolic orchestration between cancer cells and tumor microenvironment as a co-evolutionary source of chemoresistance in ovarian cancer: a therapeutic implication.
Suh DH; Kim HS; Kim B; Song YS
Biochem Pharmacol; 2014 Nov; 92(1):43-54. PubMed ID: 25168677
[TBL] [Abstract][Full Text] [Related]
16. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.
Smolková K; Plecitá-Hlavatá L; Bellance N; Benard G; Rossignol R; Ježek P
Int J Biochem Cell Biol; 2011 Jul; 43(7):950-68. PubMed ID: 20460169
[TBL] [Abstract][Full Text] [Related]
17. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
18. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
19. c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons.
Zhou Q; Lam PY; Han D; Cadenas E
J Neurochem; 2008 Jan; 104(2):325-35. PubMed ID: 17949412
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells.
Fiucci G; Ravid D; Reich R; Liscovitch M
Oncogene; 2002 Apr; 21(15):2365-75. PubMed ID: 11948420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
